Modifying the collagen matrix through inhibition of the collagen crosslinking enzyme lysyl oxidase alters the tumor microenvironment and decreases angiogenesis and progression of brain tumors in vitro and in vivo [6]. This evidence concerns the gene LOX and neoplasm.